Imigran 50mg tablets

Country: United Kingdom

Bahasa: Inggeris

Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)

Bahan aktif:

Sumatriptan succinate

Boleh didapati daripada:

CST Pharma Ltd

Kod ATC:

N02CC01

INN (Nama Antarabangsa):

Sumatriptan succinate

Dos:

50mg

Borang farmaseutikal:

Oral tablet

Laluan pentadbiran:

Oral

Kelas:

No Controlled Drug Status

Jenis preskripsi:

Valid as a prescribable product

Ringkasan produk:

BNF: 04070401; GTIN: 5055946806082

Risalah maklumat

IMIGRAN 50MG TABLETS
(sumatriptan succinate)
PATIENT INFORMATION LEAFLET
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
*
Keep this leaflet. You may need to read it again.
*
If you have any further questions, ask your doctor or pharmacist.
*
This medicine has been prescribed for you only. Do not pass it on to
others - it may harm them, even if their signs of illness are the same
as
yours.
*
If you get any side effects, talk to your doctor or pharmacist. This
includes
any possible side effects not listed in this leaflet. See section 4.
Your medicine is called Imigran 50mg Tablets but will be referred to
as
Imigran throughout the leaflet. Please note that the leaflet also
contains
information about other strength of the medicine, Imigran 100mg
Tablets
WHAT IS IN THIS LEAFLET
What Imigran is and what it is used for
What you need to know before you use Imigran
How to use Imigran
Possible side effects
How to store Imigran
Contents of the pack and other information
WHAT IMIGRAN IS AND WHAT IT IS USED FOR
EACH IMIGRAN CAPSULE-SHAPED TABLET CONTAINS A SINGLE DOSE of
sumatriptan, which belongs to a group of medicines called triptans
_(also known as 5-HT_
_1_
_receptor agonists)_.
IMIGRAN IS USED TO TREAT MIGRAINE HEADACHE.
Migraine symptoms may be caused by the temporary widening of blood
vessels in the head. Imigran is believed to reduce the widening of
these
blood vessels. This in turn helps to take away the headache and
relieve
other symptoms of a migraine attack, such as feeling or being sick
(nausea or vomiting) and sensitivity to light and sound.
WHAT YOU NEED TO KNOW BEFORE YOU USE IMIGRAN
DON’T USE IMIGRAN
*
IF YOU’RE ALLERGIC to sumatriptan, or any of the other ingredients
of this
medicine (listed in section 6)
*
IF YOU HAVE A HEART PROBLEM such as narrowing of the arteries
_(Ischaemic heart disease)_ or chest pains _(angina)_, or have already
had a
heart attack
*
IF YOU HAVE CIRCULATION PROBLEMS IN YOUR LEGS that cause cramp-like
pa

Ciri produk

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Imigran Radis 50mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
50mg sumatriptan base as the succinate salt.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Film-coated dispersible tablet
Pink film-coated, triangular shaped, biconvex tablets debossed with
‘GS 1YM’ on
one face and ‘50’ on the other.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Imigran Radis tablets are indicated for the acute relief of migraine
attacks, with or
without aura. Imigran should only be used where there is a clear
diagnosis of
migraine.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
ADULTS
Imigran Radis is indicated for the acute intermittent treatment of
migraine. It
should not be used prophylactically.
The recommended dose of Imigran should
not be exceeded.
It is advisable that Imigran be given as early as possible after the
onset of
migraine attack but it is equally effective at whatever stage of the
attack it is
administered.
The recommended dose of oral Imigran is a 50mg tablet. Some patients
may
require 100mg.
If the patient has responded to the first dose but the symptoms recur
a second
dose may be given provided that there is a minimum interval of two
hours
between the two doses. No more than 300mg should be taken in any 24
hour
period.
Patients who do not respond to the prescribed dose of Imigran Radis
should
not take a second dose for the same attack. In these cases the attack
can be
treated with paracetamol, acetylsalicylic acid, or non-steroidal anti-
inflammatory drugs. Imigran Radis may be taken for subsequent attacks.
Imigran Radis is recommended as monotherapy for the acute treatment of
migraine and should not be given concomitantly with ergotamine or
derivatives of ergotamine (including methysergide) (see section 4.3).
The tablets should be swallowed whole with water. Patients with
swallowing
difficulties may choose to disperse a tablet in a small amount of
water before
administration. Sumatriptan dispersed in water